{
    "eid": "2-s2.0-85118801915",
    "title": "A Pharmacokinetic Study of Native E.coli Asparaginase for Acute Lymphoblastic Leukemia Treated with ThaiPOG Protocol",
    "cover-date": "2021-01-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Epidemiology",
            "@code": "2713",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Oncology",
            "@code": "2730",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Public Health, Environmental and Occupational Health",
            "@code": "2739",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cancer Research",
            "@code": "1306",
            "@abbrev": "BIOC"
        }
    ],
    "keywords": [
        "allergy",
        "asparaginase",
        "Native",
        "pharmacokinetic",
        "silent inactivation"
    ],
    "authors": [
        "Phumin Chaweephisal",
        "Trai Tharnpanich",
        "Aphinya Suroengrit",
        "Pattramon Aungbamnet",
        "Panya Seksarn",
        "Darintr Sosothikul",
        "Supanun Lauhasurayotin",
        "Kanhatai Chiengthong",
        "Hansamon Poparn",
        "Piti Techavichit"
    ],
    "citedby-count": 0,
    "ref-count": 25,
    "ref-list": [
        "Monitoring of Erwinia asparaginase therapy in childhood ALL in the Nordic countries",
        "L-asparaginase for treatment of childhood acute lymphoblastic leukemia: what have we learned?",
        "A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: a Children\u2019s Cancer Group study",
        "A randomized comparison of native Escherichia coli asparaginase and polyethylene glycol conjugated asparaginase for treatment of children with newly diagnosed standard-risk acute lymphoblastic leukemia: A Children\u2019s Cancer Group study",
        "Childhood cancer incidence and survival in Thailand: A comprehensive population-based registry analysis, 1990-2011",
        "Elimination of l-asparaginase in children treated for acute lymphoblastic leukemia",
        "Monitoring asparaginase activity in middle-income countries",
        "FDA drug approval summary: pegaspargase (oncaspar) for the first-line treatment of children with acute lymphoblastic leukemia (ALL)",
        "L-asparaginase in the treatment of patients with acute lymphoblastic leukemia",
        "L-asparagine requirement and the effect of L-asparaginase on the normal and leukemic human bone marrow",
        "Clinical pharmacology of intramuscularly administered L-asparaginase",
        "Acute lymphoblastic leukemia: an assessment of international incidence, survival, and disease burden",
        "Mechanisms of cell death induced by arginase and asparaginase in precursor B-cell lymphoblasts",
        "L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia",
        "The best way to use asparaginase in childhood acute lymphatic leukaemia\u2013still to be defined?",
        "L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of rhesus monkeys and humans",
        "Erwinia asparaginase achieves therapeutic activity after pegaspargase allergy: a report from the Children\u2019s Oncology Group",
        "Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation",
        "Dynamic changes in specific anti-L-asparaginase antibodies generation during acute lymphoblastic leukemia treatment",
        "Evaluation of immunologic crossreaction of antiasparaginase antibodies in acute lymphoblastic leukemia (ALL) and lymphoma patients",
        "Effective asparagine depletion with pegylated asparaginase results in improved outcomes in adult acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 9511"
    ],
    "affiliation": {
        "affiliation-city": "Bangkok",
        "@id": "60028190",
        "affilname": "Chulalongkorn University",
        "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
        "affiliation-country": "Thailand"
    },
    "funding": [
        "Ratchadapiseksompotch Fund",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}